Validation of the Passive Surveillance Stroke Severity score in three Canadian provinces

No abstract available.

Information

Citation

Yu AYX, Austin PC, Park AL, Fang J, Hill MD, Kamal N, Field TS, Joundi RA, Peterson S, Zhao Y, Kapral MK. Can J Neurol Sci. 2024; Mar 6 [Epub ahead of print].

View Source

Contributing ICES Scientists

Research Programs

Cardiovascular

Associated Topics

Associated Sites

ICES Central

Discover More

Journal Article

16/03/2026

Hydralazine use and risk of vasculitis

Fremont D, Dhaliwal S, Canney M, Akbari A, Hundemer GL, Derebail VK, Sood MM, Massicotte-Azarniouch D. JAMA Netw Open. 2026; 9(3): e261943.

Journal Article

09/03/2026

Long-term risk of major coronary artery disease events after thrombotic microangiopathy treated with plasma exchange

Jamison HK, Bota SE, Garg AX, Kang Y, McArthur E, Huang SS, Clark WF, Sontrop JM, Eberhart AM. Am J Hematol. 2026; Mar 9 [Epub ahead of print].

Journal Article

09/03/2026

Risks of thrombosis and hemorrhage in concurrent use of anticoagulants and potential interacting prostate cancer agents

Wang TF, Clarke A, Rath M, Yoo S, Fremont D, Wu C, Ravani P, Bossé D, Talarico R, Carrier M, Sood MM. Cancer. 2026; 132(6):e70266.

See All